Yoav Sharoni

Prof. Yoav Sharoni

Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev,
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Nutrition and Cancer
Verified
Journal Article
Closed access
MKMichael Karas
Michael Karas
HAHadar Amir
Hadar Amir
DFDaniel Fishman
Daniel Fishman
Michael DanilenkoMichael Danilenko
Michael Danilenko
SSShraga Segal
Shraga Segal
Yoav SharoniYoav Sharoni
Yoav Sharoni
Recent studies have shown that high insulin-like growth factor I (IGF-I) blood level is a risk factor in breast and prostate cancer. The aim of this study was to determine whether the mitogenic activity of IGF-I in mammary cancer cells can be reduced by the dietary carotenoid lycopene. The anticancer activity of lycopene, the major tomato carotenoid, has been suggested by in vitro, in vivo, and epidemiological studies. Growth stimulation of MCF7 mammary cancer cells by IGF-I was markedly reduced by physiological concentrations of lycopene. The inhibitory effects of lycopene on MCF7 cell growth were not accompanied by apoptotic or necrotic cell death, as determined by annexin V binding to plasma membrane and propidium iodide staining of nuclei in unfixed cells. Lycopene treatment markedly reduced the IGF-I stimulation of tyrosine phosphorylation of insulin receptor substrate 1 and binding capacity of the AP-1 transcription complex. These effects were not associated with changes in the number or affinity of...

1 January 1999 in Nutrition and Cancer
Verified
Journal Article
Closed access
HAHadar Amir
Hadar Amir
MKMichael Karas
Michael Karas
JGJudith Giat
Judith Giat
Michael DanilenkoMichael Danilenko
Michael Danilenko
RLRachel Levy
Rachel Levy
Yoav SharoniYoav Sharoni
Yoav Sharoni
Lycopene, the major tomato carotenoid, has been found to inhibit proliferation of several types of cancer cells, including those of breast, lung, and endometrium. By extending the work to the HL‐60 promyelocytic leukemia cell line, we aimed to evaluate some mechanistic aspects of this effect. Particularly, the possibility was examined that the antipro‐liferative action of the carotenoid is associated with induction of cell differentiation. Lycopene treatment resulted in a concentration‐dependent reduction in HL‐60 cell growth as measured by [3H]thymidine incorporation and cell counting. This effect was accompanied by inhibition of cell cycle progression in the G0/G1 phase as measured by flow cytometry. Lycopene alone induced cell differentiation as measured by phorbol ester‐dependent reduction of nitro blue tetrazolium and expression of the cell surface antigen CD14. Results of several recent intervention studies with β‐carotene, which have revealed no beneficial effects of this carotenoid, suggest that a single dietary component cannot explain the anticancer effect of diets rich in vegetables and fruits. Thus another goal of our study was to examine whether lycopene has the ability to synergize with other natural anticancer compounds, such as 1,25‐dihydroxyvitamin D3, which when used alone are therapeutically active only at high and toxic concentrations. The combination of low concentrations of lycopene with 1,25‐dihydroxyvitamin D3 exhibited a synergistic effect on cell proliferation and differentiation and an additive effect on cell cycle progression. Such synergistic antiproliferative and differentiating effects of lycopene and other compounds found in the diet and in plasma may suggest the inclusion of the carotenoid in the diet as a cancer‐preventive measure.

1 February 2012 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
Yoav SharoniYoav Sharoni
Yoav Sharoni
KLKarin Linnewiel‐Hermoni
Karin Linnewiel‐Hermoni
MKMarina Khanin
Marina Khanin
HSHagar Salman
Hagar Salman
AVAnna Veprik
Anna Veprik
JLJoseph Levy
Joseph Levy

1 April 2015 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
KLKarin Linnewiel-Hermoni
Karin Linnewiel-Hermoni
MKMarina Khanin
Marina Khanin
Michael DanilenkoMichael Danilenko
Michael Danilenko
GZGabriel Zango
Gabriel Zango
YAYaara Amosi
Yaara Amosi
Yoav SharoniYoav Sharoni
Yoav Sharoni

1 October 2004 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
Yoav SharoniYoav Sharoni
Yoav Sharoni
Michael DanilenkoMichael Danilenko
Michael Danilenko
NDNoga Dubi
Noga Dubi
ABAnat Ben-Dor
Anat Ben-Dor
JLJoseph Levy
Joseph Levy

19 October 2006 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
KHKeren Hirsch
Keren Hirsch
AAAndrea Atzmon
Andrea Atzmon
Michael DanilenkoMichael Danilenko
Michael Danilenko
JLJoseph Levy
Joseph Levy
Yoav SharoniYoav Sharoni
Yoav Sharoni